Trial Profile
Changes In Serum IL-18 Level In Systemic Juvenile Idiopathic Arthritis Patients Who Attained Drug-Free Remission By Tocilizumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Dec 2015
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary) ; Prednisolone
- Indications Juvenile rheumatoid arthritis
- Focus Therapeutic Use
- 09 Dec 2015 New trial record